Brooklyn ImmunoTherapeutics

-$0.0289 (-4.38%) Today
+$0.0359 (+5.69%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BTX and other ETFs, options, and stocks.

About BTX

Brooklyn ImmunoTherapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in creating transformative regenerative medicine treatments for cancer, blood disorders, and monogenic diseases. It offers IRX-2, a human cell-derived cytokine therapy, studying the safety and efficacy of IRX-2 in patients with head and neck cancer in Phase 2B.

CEO
Howard J. Federoff
Employees
10
Headquarters
San Diego, California
Founded
1984

BTX Key Statistics

Market cap
36.27M
Price-Earnings ratio
—
Dividend yield
—
Average volume
600.43K
High today
$0.75
Low today
$0.59
Open price
$0.67
Volume
1.01M
52 Week high
$23.34
52 Week low
$0.59

BTX Earnings

-$0.29
-$0.19
-$0.10
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
Expected Jun 7, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure